Krill Oil for Pain in Elders
KOPE
Krill Oil for Pain and Physical Function in Older Adults
2 other identifiers
interventional
40
1 country
1
Brief Summary
Chronic musculoskeletal pain contributes to mobility disability among older adults. Nutritional interventions, like omega-3 fatty acids, may help manage pain and improve physical function. Supplementation with krill oil may offer advantages to fish oil due to better absorption and additional nutrients. This pilot study aims to assess the feasibility of a clinical trial to determine the impact of krill oil supplementation on pain and function in older adults, informing future research.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jan 2025
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 26, 2024
CompletedFirst Posted
Study publicly available on registry
August 30, 2024
CompletedStudy Start
First participant enrolled
January 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 17, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 17, 2025
CompletedApril 17, 2026
February 1, 2025
11 months
August 26, 2024
April 13, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Feasibility Metrics: Recruitment, Attrition, and Intervention Adherence
Feasibility will be assessed using prespecified benchmarks for recruitment, attrition, and intervention adherence. Feasibility criteria were defined as achieving at least 80% of the recruitment target within 12 months, less than 20% attrition, and greater than 70% adherence to the intervention.
Through study completion, up to 15 months
Medicine Acceptability Questionnaire (MAQ)
Tool designed to assess patients' perceptions and experiences of taking medications. It evaluates factors such as ease of use, taste, and overall satisfaction, providing insights into patient adherence and preferences.
6 weeks and 12 weeks
Secondary Outcomes (2)
Omega-3 Index
Baseline, 6 weeks, and 12 weeks
High-sensitivity C-reactive protein
Baseline, 6 weeks, and 12 weeks
Other Outcomes (15)
Pain, Enjoyment of Life, and General Activities (PEG) Scale
Baseline, 6 weeks, and 12 weeks
Western Ontario and McMaster Universities Arthritis Index (WOMAC)
Baseline, 6 weeks, and 12 weeks
Patient Global Impression of Change (PGIC)
6 weeks and 12 weeks
- +12 more other outcomes
Study Arms (2)
Krill oil
EXPERIMENTAL4 grams of krill oil per day
Mixed vegetable oil
PLACEBO COMPARATOR4 grams of mixed vegetable oil per day
Interventions
Eligibility Criteria
You may qualify if:
- Able to provide informed consent
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged ≥60 years
- Exhibiting chronic musculoskeletal pain of the hip, knees, or lower back (\>3 months)
- Average pain ≥4 on a 0-10 numeric rating scale
- Exhibiting moderate mobility limitations (Short Physical Performance Battery score 4-10)
- Ability to take oral supplements and be willing to adhere to the supplementation regimen
- Agreement to adhere to Lifestyle Considerations throughout study duration
You may not qualify if:
- Any known coagulation or bleeding disorders
- Standing regimen of anticoagulants or full-dose aspirin
- Regular use of opioids or high-dose NSAIDs
- Taking medication known to affect muscle (e.g. steroids)
- Taking selective serotonin reuptake inhibitors (SSRIs)
- Omega-3 supplementation within the past 3 months
- High consumption of fatty fish (\>2 servings/week)
- Habitual supplementation with other complementary medicines/supplements that may affect the study results, including St. John's Wort
- Known allergy to seafood
- Clinically significant conditions: diabetes, severe cardiovascular disease, seizure disorders, uncontrolled hypertension (\>150/90mmhg at baseline), cancer or cancer that has been in remission \>5 years
- History of atrial fibrillation or atrial flutter
- Dementia
- History of smoking, alcohol abuse, or illicit drug use
- Ambulatory impairments which would limit the ability to perform physical function tests
- Treatment with another investigational drug or other intervention within 3 months
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Floridalead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
UF Claude D. Pepper Older Americans Independence Center
Gainesville, Florida, 32610, United States
Related Publications (6)
Sibille KT, King C, Garrett TJ, Glover TL, Zhang H, Chen H, Reddy D, Goodin BR, Sotolongo A, Petrov ME, Cruz-Almeida Y, Herbert M, Bartley EJ, Edberg JC, Staud R, Redden DT, Bradley LA, Fillingim RB. Omega-6: Omega-3 PUFA Ratio, Pain, Functioning, and Distress in Adults With Knee Pain. Clin J Pain. 2018 Feb;34(2):182-189. doi: 10.1097/AJP.0000000000000517.
PMID: 28542024BACKGROUNDStonehouse W, Benassi-Evans B, Bednarz J, Vincent AD, Hall S, Hill CL. Krill oil improved osteoarthritic knee pain in adults with mild to moderate knee osteoarthritis: a 6-month multicenter, randomized, double-blind, placebo-controlled trial. Am J Clin Nutr. 2022 Sep 2;116(3):672-685. doi: 10.1093/ajcn/nqac125.
PMID: 35880828BACKGROUNDSuzuki Y, Fukushima M, Sakuraba K, Sawaki K, Sekigawa K. Krill Oil Improves Mild Knee Joint Pain: A Randomized Control Trial. PLoS One. 2016 Oct 4;11(10):e0162769. doi: 10.1371/journal.pone.0162769. eCollection 2016.
PMID: 27701428BACKGROUNDAlkhedhairi SA, Aba Alkhayl FF, Ismail AD, Rozendaal A, German M, MacLean B, Johnston L, Miller AA, Hunter AM, Macgregor LJ, Combet E, Quinn TJ, Gray SR. The effect of krill oil supplementation on skeletal muscle function and size in older adults: A randomised controlled trial. Clin Nutr. 2022 Jun;41(6):1228-1235. doi: 10.1016/j.clnu.2022.04.007. Epub 2022 Apr 20.
PMID: 35504165BACKGROUNDLaslett LL, Scheepers LEJM, Antony B, Wluka AE, Cai G, Hill CL, March L, Keen HI, Otahal P, Cicuttini FM, Jones G. Krill Oil for Knee Osteoarthritis: A Randomized Clinical Trial. JAMA. 2024 Jun 18;331(23):1997-2006. doi: 10.1001/jama.2024.6063. Erratum In: JAMA. 2024 Sep 26. doi: 10.1001/jama.2024.20532.
PMID: 38776073BACKGROUNDTamargo JA, Carvajal E, Simic K, Przkora R, Anton SD, Cruz-Almeida Y. Pilot Randomized Controlled Trial of Krill Oil Supplementation for Chronic Musculoskeletal Pain in Older Adults. J Nutr. 2026 Mar 31:101517. doi: 10.1016/j.tjnut.2026.101517. Online ahead of print.
PMID: 41933837RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Javier A Tamargo, PhD
University of Florida
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 26, 2024
First Posted
August 30, 2024
Study Start
January 17, 2025
Primary Completion
December 17, 2025
Study Completion
December 17, 2025
Last Updated
April 17, 2026
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share